PATENT CLAIM ANALYSIS

Application Number: 15868328
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["424", "186100"]

Abstract:
The present invention provides, among other things, antibody agents (e.g., antibodies, and/or antigen-binding fragments thereof) that bind to DV epitopes, as well as compositions containing them and methods of designing, providing, formulating, using, identifying and/or characterizing them. In some embodiments, provided antibody agents show significant binding to a plurality of DV serotypes. In some embodiments, provided antibody agents show significant binding to all four DV serotypes. Such antibody agents are useful, for example, in the prophylaxis, treatment, diagnosis, and/or study of DV.

Claim (Index 40):
The antibody agent of  claim 39 , wherein the antibody agent:\n (a) competes with 4E5A for binding to an epitope within each of SEQ ID NO. 17 (EDIII-DV1), SEQ ID NO. 18 (EDIII-DV2), SEQ ID NO. 19 (EDIII-DV3), SEQ ID NO. 20 (EDIII-DV4); (b) shows enhanced affinity for the epitope within SEQ ID NO. 20 (EDIII-DV4) relative to that shown by 4E5A; and/or (c) shows comparable affinity to that shown by 4E5A for the epitopes within each of SEQ ID NO. 17 (EDIII-DV1), SEQ ID NO. 18 (EDIII-DV2), and SEQ ID NO. 19 (EDIII-DV3).

Metadata:
- Claim Count in Document: 17.0
- Percentile: 86.0
- Lexical Diversity: 1.70492
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14620144', '13951066', '15291199', '14921701', '14600306']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8300202505866207
- 35 USC 102 Novelty (BERT): 0.6354940565910641
- Combined Prediction Score: 0.810567631187065
- Mean Citation Score: 560.121976
- Max Citation Score: 718.4655
- Similarity Product: 536.6411257002354

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test